Endra Life Sciences GAAP EPS of -$2.10 misses by $0.15

* Endra Life Sciences press release [https://seekingalpha.com/pr/20309530-endra-life-sciences-recaps-major-milestones-and-new-strategic-initiatives-announces-third] (NDRA [https://seekingalpha.com/symbol/NDRA]): Q3 GAAP EPS of -$2.10 misses by $0.15.
*
For the third quarter of 2025, the company’s cash burn from operations decreased 30% to $1.2 million compared with $1.7 million in the same quarter of 2024, reflecting cost-optimization initiatives including streamlined staffing, reduced overhead and a leaner operating model.

*
As of September 30, 2025, ENDRA had $0.8 million in cash and cash equivalents. Subsequent to the quarter end, ENDRA raised $4.9 million in gross proceeds through a private placement.

MORE ON ENDRA LIFE SCIENCES

* ENDRA Life Sciences announces at-market private placement of up to $14.4M [https://seekingalpha.com/news/4503570-endra-life-sciences-announces-at-market-private-placement-of-up-to-144m]
* Seeking Alpha’s Quant Rating on Endra Life Sciences [https://seekingalpha.com/symbol/NDRA/ratings/quant-ratings]
* Historical earnings data for Endra Life Sciences [https://seekingalpha.com/symbol/NDRA/earnings]
* Financial information for Endra Life Sciences [https://seekingalpha.com/symbol/NDRA/income-statement]